US energy storage set another quarterly record, powered largely by seven new gigascale battery installations exceeding one gigawatt-hour each, according to a report from Benchmark Mineral Intelligence and the Solar Energy Industries Association. Behind-the-meter batteries also grew, with data centers accounting for roughly three-quarters of new commercial installations, even as residential battery installations are projected to fall 16% in 2026 after a supporting tax credit expired in 2025.
Google announced a 13 billion euro ($15.1 billion) investment to build out AI infrastructure in Finland, making it the company's largest single investment ever made in Europe. The move underscores Finland's growing appeal to hyperscalers seeking abundant land and power resources that are increasingly scarce elsewhere on the continent.
OpenAI says an unreleased AI model produced a proof addressing the Navier-Stokes existence and smoothness problem, one of the seven Millennium Prize math problems, completing the work in 88 hours. The proof reportedly identifies a scenario where the fluid-dynamics equations break down mathematically, though researchers stress this doesn't mean real fluids like water would physically behave that way.
ASML is developing a larger 12-inch mask format for its next-generation High-NA EUV lithography systems, letting them print chips as large as those made with current EUV tools. The company expects a pilot line by 2031 and high-volume production by 2033, with CTO Marco Pieters saying the shift could boost system productivity by 40% if the industry adopts it together.
Researchers studying the remains of an ancient city in Asia have found evidence of sophisticated engineering and social organization, according to a report highlighted by Nature. The findings point to coordinated planning and construction techniques that allowed the settlement to function as a complex urban center.
Researchers examining a set of unusual ancient fossils found evidence that the earliest insects were far more anatomically varied than previously assumed. The specimens display body structures that don't fit neatly into existing insect classification schemes, complicating the picture of how insects first diversified.
A large-scale genetic study analyzed data from roughly one million people to identify genetic variants associated with the Big Five personality traits—openness, conscientiousness, extraversion, agreeableness, and neuroticism. The research aimed to uncover the biological underpinnings of personality by pinpointing specific genomic regions correlated with these traits.
A research team mined all 214.5 million structure predictions in Google DeepMind's AlphaFold database to search for undiscovered 7TM (seven-transmembrane) folds resembling G-protein-coupled receptors. Using the rhodopsin structure as a reference and the TM-align algorithm, they identified TM184C as a previously unrecognized GPCR-like protein involved in regulating cell-to-cell exchange and autophagy. The analysis required processing 24 tebibytes of compressed structural data on university supercomputing clusters.
Researchers analyzed whole-genome sequencing data from 1,001 prostate cancer patients (1,172 tumour samples) collected through the PPCG consortium, applying computational tools to classify structural variants, including simple, complex, and chromothripsis-related genomic rearrangements. The team combined breakpoint detection, copy number segmentation, and statistical tests to build a detailed picture of mutational processes driving the disease.
Scientists have developed a drug delivery approach that targets specific structures within individual cells rather than simply reaching a cell as a whole. This subcellular precision aims to route therapeutic payloads to particular organelles or compartments where they can act most effectively.
Scientists are developing intranasal vaccines designed to trigger immunity directly in the nose and upper airway, the entry point for many respiratory pathogens. Unlike injected vaccines that mainly prevent severe illness, these formulations aim to stop infection and transmission before a virus can spread further.
Researchers are redesigning drug molecules and delivery systems so a single injection or implant can maintain therapeutic effects for weeks, months, or even years instead of requiring daily dosing. Techniques include chemical modifications that slow drug breakdown, polymer depots, and implantable devices that release medication gradually over extended periods.
GoKawiil